Filing Details
- Accession Number:
- 0001209191-22-050956
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-09-21 20:00:33
- Reporting Period:
- 2022-09-19
- Accepted Time:
- 2022-09-21 20:00:33
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1501756 | Adverum Biotechnologies Inc. | ADVM | Biological Products, (No Disgnostic Substances) (2836) | 205258327 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1903088 | Setareh Seyedkazemi | C/O Adverum Biotechnologies, Inc. 100 Cardinal Way Redwood City CA 94063 | Chief Development Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2022-09-19 | 6,058 | $1.07 | 47,875 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The sales reported on this Form 4 were effected to satisfy certain tax obligations of the Reporting Person incurred with the vesting and settlement of certain performance stock units.
- The reporting person's sale of Adverum common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934 with the reporting person's purchase of the same number of shares of Adverum common stock at a price of $0.84 per share on May 23, 2022. The reporting person has paid to Adverum $1,390.91, representing the full amount of the profit realized in connection with the short-swing transaction.
- Price reported is a weighted-average sale price. The shares were sold at prices ranging from $1.069589 to $1.07. The reporting person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
Billionaire Hedge Funds
